Elixinol Global Ltd

Elixinol Global Ltd

Elixinol Global Limited (ASX: EXL; OTCQX: ELLXF) through its businesses has a global presence in the cannabis industry, including the use of CBD dietary supplements from cannabis, food and wellness products, as well as the cultivation and manufacture of medicated cannabis products.
Marijuana Infused Products
1d 5d 1m 6m 1y Max
1d 5d 1m 6m 1y Max

Elixinol Global Ltd News

13 Jun

EXL Raises A$50 Million to Support U.S. Expansion

Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, recently announced that its parent company Elixinol Global (EXL) has raised A$50...

04 Jun

Elixinol Participates In FDA's First CBD Hearing, Says Guidance, Clarity Will Benefit 'Good Players'

The Food and Drug Administration held its first-ever hearing on CBD Friday, and market leaders gave testimony on the state of the industry and what they hope it will look like going forward.  One participant,...

03 Jun

Elixinol Issues a Statement Following the Public FDA Hearing in Washington, D.C. on Friday, May 31

DENVER, June 03, 2019 -- Elixinol issued the following statement regarding the public FDA hearing in Washington, D.C. on Friday, May 31. “We support the FDA’s intentions, we.

15 May

Elixinol Granted CBD Processor Research Partner Authorization by New York State

Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that it has been officially granted a CBD Processor Research...

14 May

Elixinol Partners with Cambrian Alliance

Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that they have partnered with Cambrian Alliance (CA), one of...

01 May

Bulls And Bud Of The Week: True Leaf Medicine And PLUS Products

Last week, Elixinol (OTC: ELLXF) snapped up a 25-percent stake in Altmeds, a company that makes CBD products for pets. Although some folks might dismiss the market for CBD-based pet products, it’s actually...

24 Apr

Elixinol to Acquire 25 Percent Stake in US-Based CBD Pet Products Brand Pet Releaf

Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that they have purchased a 25 percent stake in Altmeds LLC, maker...

17 Apr

Elixinol and KBMD Health Launch New Hemp CBD Extract

Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, announces its latest product in partnership with Ken Brown, MD of KBMD Health,...

15 Apr

Elixinol Receives U.S. Hemp Authority Certification

Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that it has received U.S. Hemp Authority™ Certification. The...

12 Apr

Elixinol Global Limited strengthens Board with the addition of consumer retail specialist as Non-Executive

DENVER, April 12, 2019 -- Elixinol Global Limited (EXL or the Company) (ASX:EXL; OTCQX:ELLXF), a global company operating in the industrial hemp, dietary supplements and.

Load more

About Elixinol Global Ltd

Elixinol Global Limited (ASX: EXL; OTCQX: ELLXF) through its businesses has a global presence in the cannabis industry including hemp-derived CBD dietary supplements, food and wellness products, as well as the cultivation and manufacture of medicinal cannabis products. Elixinol Global’s businesses include:

  • Elixinol USA, which was founded in 2014, is a manufacturer and global distributor of industrial hemp-based dietary supplement and skin care products, with operations based out of Colorado, USA. 
  • Hemp Foods Australia, which was founded in 1999, is a leading hemp food wholesaler, retailer, manufacturer and exporter of bulk and branded raw materials, and finished products. 
  • Nunyara was founded in 2014 to participate in the emerging Australian medicinal cannabis market and submitted license applications for cultivation and manufacture to the Office of Drug Control in early 2018. These applications are currently pending approval. 

Team

Andrew Duff
Non-Executive Director and Chairman
Stratos Karousos
Non-Executive Director
Paul Benhaim
Executive Director and Chief Executive Officer
Linda McLeod
Managing Director
Ron Dufficy
Chief Financial Officer and Company Secretary

Participation in events

$ 1.43
-1.00%
Open:
1.44
High:
1.45
Low:
1.41
Share volume:
90.146 K
Total value:
156.855 K
Market cap:
105.341 M
Symbol:
ELLXF